Completed Equality Screenings - Quarter 3 - October 2013 - December 2013
Date published:
In fulfilling the commitments within its Equality Scheme the Department equality screens policies to assess the impact and determine if a full Equality Impact Assessment (EQIA) is required.
Documents
- General Ophthalmic Services (Amendment) Regulations (Northern Ireland) 2013
- NICE Clinical Guidelines – CG156 Fertility: assessment and treatment for people with fertility problems
- NICE Clinical Guideline CG 168 - Varicose veins in the legs
- NICE Clinical Guideline CG169 - Acute kidney injury
- NICE Clinical Guideline CG170 - Autism - management of autism in children and young people
- NICE Clinical Guideline CG171 - Urinary incontinence in women
- NICE Technology Appraisal - TA 295 Everolimus in combination with an aromatase inhibitor for the treatment of HER2 negative, oestrogen receptor positive locally advanced or metastatic breast cancer after prior endocrine therapy
- NICE Technology Appraisal – TA296 Crizotinib for the treatment of previously treated non-small-cell lung cancer associated with an anaplastic lymphoma kinase fusion gene
- NICE Technology Appraisal – TA298 Ranibizumab for treating choroidal neovascularisation associated with pathological myopia
- NICE Technology Appraisal – TA299 Bosutinib for previously treated chronic myeloid leukaemia
- NICE Technology Appraisal – TA300 Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C in children and young people